Detalhe da pesquisa
1.
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 390(10101): 1489-1498, 2017 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28728956
2.
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers.
NEJM Evid
; 1(1): EVIDoa2100001, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38319241
3.
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation.
Clin Pharmacol Drug Dev
; 5(4): 296-305, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27310330